JPRN-jRCT2011200021已完成3 期
A phase III clinical study of MR13A9 in hemodialysis patients with pruritus
Shimizu Yoshitaka0 个研究点目标入组 172 人开始时间: 2021年1月29日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patient with Chronic Kidney Disease (CKD) has been on hemodialysis 3 times per week
- •- Patient receiving treatment for itch
- •- Patient has a baseline NRS score > 4
排除标准
- •- Patient has pruritus cause other than CKD or its complications
- •- Patients has hepatic cirrhosis
- •- Patient has a known history of allergic reaction to opiates
研究者
相似试验
已完成
3 期
A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.Uremic PruritusNCT04711603Kissei Pharmaceutical Co., Ltd.178
已完成
2 期
A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.Uremic PruritusNCT03802617Kissei Pharmaceutical Co., Ltd.247
未知
2 期
Phase II clinical study of CIM331 (hemodialysis)JPRN-jRCT2080222909CHUGAI PHARMACEUTICAL CO., LTD60
尚未招募
不适用
Clinical effects of H12 hemodialyzer(AN69 membrane) in hemodialysis patients with uremic pruritusChronic renal failureJPRN-UMIN000002033agoya University Hospital Division of Nephrology40
未知
Unknown
Clinical Pharmacology Study of TS-143 in Hemodialysis and Non-dialysis Chronic Kidney Disease PatientsChronic Kidney DiseaseJPRN-jRCT2080223328Taisho Pharmaceutical co., LTD28